Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Launch date
Employees
Market cap
AUD3.8m
Enterprise valuation
AUD200m (Public information from Sep 2024)
Share price
$0.0056 SRNE
San Diego California (HQ)
Authorizing premium user...